Advanced Search

Clinical Nutrition Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Jeremy Nightingale

    Jeremy Nightingale

    rtment of Nutrition and Intestinal Failure , St Mark's Hospital, Harrow, Middlesex, UK

  • No photo

    Jon Shaffer

    Gastroenterology Department, Salford Royal NHS FoundationTrust, Salford, UK

Section Topics

  • » Bile acids, bile duct tumors, bile tract infections, endoscopic & sclerosing
  • » Complementary & alternative nutritional therapies
  • » GE intestinal malignancies (non liver)
  • » Home enteral nutrition
  • » Home parenteral nutrition
  • » In-hospital nutrition team
  • » MICI/IBD
  • » Medical liver diseases (virus, cirrhosis, NASH, etc.)
  • » Nutritional assessment
  • » Obesity, including bariatric procedures
  • » Other GE diseases (non MICI, non malignant)
  • » Surgery in GE diseases (preoperative excluding intestinal failure)
  • » Surgery in intestinal failure
  • » Surgery in liver diseases (including liver transplant, etc.)
  • » The critically ill (ICU)
  • » Tools in GE & liver metabolism

LATEST EVALUATION

The authors used a metabolomics approach to identify small molecules in plasma that are associated with the risk of developing cardiovascular disease. Subsequent studies with germ-free mice demonstrated the critical role that the microbial species...

Karen Nelson, J Craig Venter Institute, USA. F1000 Microbiology

8 Must Read

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

20
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.

Wang Z, Klipfell E, Bennett BJ, Koeth R, ..., Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Nature. 2011 Apr 7; 472(7341):57-63

5 Evaluations, most recent by

Karen Nelson, J Craig Venter Institute, USA. F1000 Microbiology

  • New Finding
  • Good for Teaching
  • Novel Drug Target
  • Technical Advance

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000